Form D · Biotechnology
ValCor Cath Inc.
Ottawa Hills, OH · CIK 0001979820
Offering snapshot reported Aug 14, 2025 · SEC filing
- Reported sold
- $4.25M Offering amount: $4.25M
- Investors reported
- 52 Form D · investor count
- Minimum accepted
- Not reported Reported outside-investor minimum
- First sale
- May 19, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2025 | Amendment | $4,250,000 | No comparison | 52 | SEC filing |
| Jun 8, 2023 | Initial | $1,074,981 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Not reported
- Exemptions
- Not reported
- Duration over one year
- Not reported
- Business combination
- Not reported
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-483708
$2,000,000 added to extend the initial offering of $2,250,000
Source: Form D, filed Aug 14, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Howard Bobrow | Executive |
| Michael Bunker | Director |
| Diane Chelsea | Executive |
| Eugene Jung | Director, Executive |
| Matthew Pollman | Director |
| P. Kasi Ramanathan | Director, Executive |
| Gary Smith | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4146 Halifax Road
Ottawa Hills, OH, 43606
Ottawa Hills, OH, 43606